Literature DB >> 26280981

Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.

Georg Kuhnert1, Ronald Boellaard2, Sergej Sterzer1, Deniz Kahraman1, Matthias Scheffler3, Jürgen Wolf3, Markus Dietlein1, Alexander Drzezga1, Carsten Kobe4.   

Abstract

BACKGROUND: In oncological imaging using PET/CT, the standardized uptake value has become the most common parameter used to measure tracer accumulation. The aim of this analysis was to evaluate ultra high definition (UHD) and ordered subset expectation maximization (OSEM) PET/CT reconstructions for their potential impact on quantification. PATIENTS AND METHODS: We analyzed 40 PET/CT scans of lung cancer patients who had undergone PET/CT. Standardized uptake values corrected for body weight (SUV) and lean body mass (SUL) were determined in the single hottest lesion in the lung and normalized to the liver for UHD and OSEM reconstruction. Quantitative uptake values and their normalized ratios for the two reconstruction settings were compared using the Wilcoxon test. The distribution of quantitative uptake values and their ratios in relation to the reconstruction method used were demonstrated in the form of frequency distribution curves, box-plots and scatter plots. The agreement between OSEM and UHD reconstructions was assessed through Bland-Altman analysis.
RESULTS: A significant difference was observed after OSEM and UHD reconstruction for SUV and SUL data tested (p < 0.0005 in all cases). The mean values of the ratios after OSEM and UHD reconstruction showed equally significant differences (p < 0.0005 in all cases). Bland-Altman analysis showed that the SUV and SUL and their normalized values were, on average, up to 60 % higher after UHD reconstruction as compared to OSEM reconstruction.
CONCLUSION: OSEM and HD reconstruction brought a significant difference for SUV and SUL, which remained constantly high after normalization to the liver, indicating that standardization of reconstruction and the use of comparable SUV measurements are crucial when using PET/CT.

Entities:  

Keywords:  Lung cancer; PET; Quantification; SUV

Mesh:

Substances:

Year:  2015        PMID: 26280981     DOI: 10.1007/s00259-015-3165-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  26 in total

1.  Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.

Authors:  Deniz Kahraman; Matthias Scheffler; Thomas Zander; Lucia Nogova; Adriaan A Lammertsma; Ronald Boellaard; Bernd Neumaier; Roland T Ullrich; Arne Holstein; Markus Dietlein; Jürgen Wolf; Carsten Kobe
Journal:  J Nucl Med       Date:  2011-11-07       Impact factor: 10.057

2.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

3.  Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma.

Authors:  Agostino Chiaravalloti; Roberta Danieli; Paolo Abbatiello; Barbara Di Pietro; Laura Travascio; Maria Cantonetti; Manlio Guazzaroni; Antonio Orlacchio; Giovanni Simonetti; Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

4.  Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma.

Authors:  S F Barrington; J E MacKewn; P Schleyer; P K Marsden; N G Mikhaeel; W Qian; P Mouncey; P Patrick; B Popova; P Johnson; J Radford; M J O'Doherty
Journal:  Ann Oncol       Date:  2010-09-02       Impact factor: 32.976

5.  Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods.

Authors:  Cornelia Brendle; Jürgen Kupferschläger; Konstantin Nikolaou; Christian la Fougère; Sergios Gatidis; Christina Pfannenberg
Journal:  Eur J Radiol       Date:  2014-11-01       Impact factor: 3.528

6.  Variability of Hepatic 18F-FDG Uptake at Interim PET in Patients With Hodgkin Lymphoma.

Authors:  Domenico Rubello; Pierre Gordien; Camille Morliere; Martine Guyot; Laurence Bordenave; Patrick M Colletti; Elif Hindié
Journal:  Clin Nucl Med       Date:  2015-08       Impact factor: 7.794

7.  Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.

Authors:  Perrine Tylski; Simon Stute; Nicolas Grotus; Kaya Doyeux; Sébastien Hapdey; Isabelle Gardin; Bruno Vanderlinden; Irène Buvat
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

8.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

9.  Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

Authors:  Charline Lasnon; Cédric Desmonts; Elske Quak; Radj Gervais; Pascal Do; Catherine Dubos-Arvis; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-06       Impact factor: 9.236

10.  Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.

Authors:  Go Akamatsu; Katsuhiko Mitsumoto; Takafumi Taniguchi; Yuji Tsutsui; Shingo Baba; Masayuki Sasaki
Journal:  Eur J Radiol       Date:  2013-10-06       Impact factor: 3.528

View more
  15 in total

1.  Developments in oncological positron emission tomography/computed tomography assessment.

Authors:  Carsten Kobe; Ronald Boellaard; Jürgen Wolf; Georg Kuhnert; Markus Dietlein; Bernd Neumaier; Alexander Drzezga; Deniz Kahraman
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake.

Authors:  Xin Li; Steven P Rowe; Jeffrey P Leal; Michael A Gorin; Mohamad E Allaf; Ashley E Ross; Kenneth J Pienta; Martin A Lodge; Martin G Pomper
Journal:  J Nucl Med       Date:  2016-12-08       Impact factor: 10.057

Review 3.  Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review.

Authors:  Bruno Hochhegger; Matheus Zanon; Stephan Altmayer; Gabriel S Pacini; Fernanda Balbinot; Martina Z Francisco; Ruhana Dalla Costa; Guilherme Watte; Marcel Koenigkam Santos; Marcelo C Barros; Diana Penha; Klaus Irion; Edson Marchiori
Journal:  Lung       Date:  2018-10-09       Impact factor: 2.584

4.  All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting.

Authors:  Sally F Barrington; Tom Sulkin; Adam Forbes; Peter W M Johnson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-02       Impact factor: 9.236

5.  Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden.

Authors:  Sally F Barrington; Michel Meignan
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

6.  Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.

Authors:  Vikas Prasad; Ingo G Steffen; Gerd Diederichs; Marcus R Makowski; Peter Wust; Winfried Brenner
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

7.  Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network.

Authors:  Brenda F Kurland; Lanell M Peterson; Andrew T Shields; Jean H Lee; Darrin W Byrd; Alena Novakova-Jiresova; Mark Muzi; Jennifer M Specht; David A Mankoff; Hannah M Linden; Paul E Kinahan
Journal:  J Nucl Med       Date:  2018-10-25       Impact factor: 10.057

8.  Metabolic Tumour Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma.

Authors:  Jasmin Mettler; Horst Müller; Conrad-Amadeus Voltin; Christian Baues; Bernd Klaeser; Alden Moccia; Peter Borchmann; Andreas Engert; Georg Kuhnert; Alexander E Drzezga; Markus Dietlein; Carsten Kobe
Journal:  J Nucl Med       Date:  2018-06-07       Impact factor: 10.057

Review 9.  FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.

Authors:  Sally F Barrington; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236

10.  Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability.

Authors:  Liran Domachevsky; Hanna Bernstine; Meital Nidam; Dan Stein; Natalia Goldberg; Dorit Stern; Ifat Abadi-Korek; David Groshar
Journal:  Contrast Media Mol Imaging       Date:  2017-05-30       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.